Wilmington-based Charles River Laboratories International Inc. said it has a deal with AstraZeneca PLC to perform early-stage experimental drug testing for the giant drug company before the products move to clinical trials. Charles River provides products and services to help pharmaceutical firms, government agencies, and academic institutions accelerate research and drug development efforts. Charles River said the three-year pact runs into 2015. Financial details weren’t disclosed.
Charles River Labs in deal with AstraZeneca
Globe wires October 18, 2012
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢